Duloxetine Hydrochloride
Product Images NDC 46708-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 46708-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

20mg Hdpe Bottle Pack (Duloxetine 20)

20mg Hdpe Bottle Pack (Duloxetine 20)
This appears to be a description of a medication called Duloxetine, which comes in capsules containing 2.4mg of the active ingredient (Duvetine). The medication is meant to be kept in a closed container out of reach of children, stored at 5°C (around 41°F), and should only be taken as directed by a healthcare provider. The packaging includes a medication guide for patients and is available in a 30-capsule quantity. Additional information, such as expiration date, is unavailable from the given text.*
FDA Label Image

30mg Hdpe Bottle Pack (Duloxetine 30)

30mg Hdpe Bottle Pack (Duloxetine 30)
FDA Label Image

60mg Hdpe Bottle Pack (Duloxetine 60)

60mg Hdpe Bottle Pack (Duloxetine 60)
Each capsule contains 67.3 mg of duloxetine hydrochloride USP equivalent to 60 mg duloxetine. Please refer to accompanying literature for dosage instructions. The capsules should be kept in a tightly closed container, stored at a temperature of 25°C (77°F) with excursion permitted to 15° to 30°C (59°F to 86°F), and kept out of the reach of children. Do not use if inner seal is missing or broken. This medication should only be dispensed by a USP Controlled Room pharmacy. Dispense the accompanying Medication Guide to each patient. Manufactured by Alembic Pharmaceuticals Limited's Formulation Division in India. This product is only available by prescription and comes in a package containing 30 capsules.*
FDA Label Image

Duloxetine-figure-1 (Duloxetine Figure 1)

Duloxetine-figure-1 (Duloxetine Figure 1)
FDA Label Image

Duloxetine-figure-2 (Duloxetine Figure 2)

Duloxetine-figure-2 (Duloxetine Figure 2)
This document shows the percentage of patients who improved in pain from baseline when taking either Duloxetine 60mg BID or Duloxetine 60mg QD compared to placebo. The chart includes data points at 210, 220, 230, 240, 250, 260, 270 with corresponding percent improvements.*
FDA Label Image

Figure-3 (Duloxetine Figure 3)

Figure-3 (Duloxetine Figure 3)
FDA Label Image

Figure-4 (Duloxetine Figure 4)

Figure-4 (Duloxetine Figure 4)
This document appears to be a graph showing the percentage of patients improved after taking Duloxetine 60 mg once daily. The x-axis ranges from 210 to 280 and the y-axis ranges from 0 to 100. The graph shows that 100% of patients experienced improvement. The text "Percent Improvement in Pain from Baseline (BOCF)" indicates that the patients were likely experiencing pain prior to treatment with Duloxetine.*
FDA Label Image

Figure-5 (Duloxetine Figure 5)

Figure-5 (Duloxetine Figure 5)
This is a chart that shows the percentage of patients who experienced improvement in pain from baseline after taking a placebo or Duloxetine in doses of 60/120 mg once daily. The chart includes numbers ranging from 0 to 100, representing different levels of improvement.*
FDA Label Image

Duloxetine-structure (Duloxetine Structure)

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.